Registered entities
Glycomimetics Inc
Reg. No. 1253689United States
Innovation
69 patent families (28 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 23,559 times.
| Year | Filings |
|---|---|
| 2013 | 11 |
| 2014 | 12 |
| 2015 | 9 |
| 2016 | 10 |
| 2017 | 13 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 14 |
| 2021 | 17 |
| 2022 | 18 |
| 2023 | 18 |
| 2024 | 11 |
Investor mix
10 investors on record; lead investors include New Enterprise Associates, Novartis, Anthem Capital Management, Alliance Technology Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Private equity | 1 | 10% |
| Other / undisclosed | 3 | 30% |
